Key Insights

Highlights

Treatment Research

8 treatments under study, led by Diflucan 150 Mg Cápsulas Duras

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Phase 2 (2)
Phase 3 (1)

Trial Status

Unknown3

Clinical Trials (3)

Showing 3 of 3 trials
NCT04813822Phase 2UnknownPrimary

Study Evaluating the Efficacy and Safety of Miconazole Nitrate + Domiphen Bromide Vaginal Cream in the Treatment of Subjects With Acute Vulvovaginal Candidiasis

NCT04956419Phase 3UnknownPrimary

A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Acute Vulvovaginal Candidiasis

SYFe2d356b1d3114ce59923bb7fb7e0ce9ePhase 2Unknown

A double-blind, randomised, dose-finding trial to assess the efficacy, safety and pharmacokinetics of a single dose of albaconazole versus fluconazole and placebo in the treatment of acute Candida vulvovaginitis

Showing all 3 trials

Research Network

Common Treatments

  • Diflucan 150 Mg Cápsulas Duras1
  • Canadiol 100 Mg Cápsulas1
  • Miconazole Nitrate1
  • Miconazole Nitrate 2 Domiphen Bromide Low Dose1
  • Albaconazole1

Active Sponsors

  • Jiangsu HengRui Medicine Co., Ltd.1
  • Palau Pharma S.L.1
  • Aesculape CRO Belgium BV1

Top Investigators

Activity Timeline